Sun Pharma Q2FY17

1. Consolidated net profit up 90.2% at Rs 2,235 cr v/s Rs 1,299.2 cr (YoY) 
2. Consolidated total income up 20.2 % at Rs 8,265 cr v/s Rs 6,873.3 cr (YoY) 
3. Consolidated EBITDA up 69.1% at Rs 3,167.7 cr v/s Rs 1,873 cr (YoY) 
4. Consolidated EBITDA margin at 38.3% v/s 27.2%(YoY)
5. Finance costs at Rs 53.7 cr v/s Rs 158.2 cr (YoY) 
6. Tax expense at Rs 441.6 cr v/s Rs 294.6 cr (YoY)